Evidence map›Paper›PMID 33668629›Full record

ArticleChildren (Basel, Switzerland)2021

Variability of Prognostic Results Based on Biological Parameters in Sickle Cell Disease Cohort Studies in Children: What Should Clinicians Know?

Julie Sommet, Enora Le Roux, Bérengère Koehl, Zinedine Haouari, Damir Mohamed, André Baruchel, Malika Benkerrou, Corinne Alberti

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julie SommetAP-HP, Hôpital Robert-Debré, Unité d'épidémiologie clinique, Inserm, CIC 1426, 48 bd Serurier, F-75019 Paris, France.
Enora Le RouxAP-HP, Hôpital Robert-Debré, Unité d'épidémiologie clinique, Inserm, CIC 1426, 48 bd Serurier, F-75019 Paris, France.
Bérengère KoehlAP-HP, Hôpital Robert-Debré, Centre de Référence de la Drépanocytose, Service d'Hématologie, 48 bd Serurier, F-75019 Paris, France.
Zinedine HaouariAP-HP, Hôpital Robert-Debré, Centre de Référence de la Drépanocytose, Service d'Hématologie, 48 bd Serurier, F-75019 Paris, France.
Damir MohamedAP-HP, Hôpital Robert-Debré, Unité d'Epidémiologie Clinique, 48 bd Serurier, F-75019 Paris, France.
André BaruchelAP-HP, Hôpital Robert-Debré, Service d'Hématologie, 48 bd Serurier, F-75019 Paris, France.
Malika BenkerrouUniversité de Paris, UMR 1123, ECEVE, 10 av de Verdun, F-75010 Paris, France.
Corinne AlbertiAP-HP, Hôpital Robert-Debré, Unité d'épidémiologie clinique, Inserm, CIC 1426, 48 bd Serurier, F-75019 Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany pediatric studies describe the association between biological parameters (BP) and severity of sickle cell disease (SCD) using different methods to collect or to analyze BP. This article assesses the methods used for collection and subsequent statistical analysis of BP, and how these impact prognostic results in SCD children cohort studies.

methodsFirstly, we identified the collection and statistical methods used in published SCD cohort studies. Secondly, these methods were applied to our cohort of 375 SCD children, to evaluate the association of BP with cerebral vasculopathy (CV).

resultsIn 16 cohort studies, BP were collected either once or several times during follow-up. The identified methods in the statistical analysis were: (1) one baseline value per patient (2) last known value; (3) mean of all values; (4) modelling of all values in a two-stage approach. Applying these four different statistical methods to our cohort, the results and interpretation of the association between BP and CV were different depending on the method used.

conclusionThe BP prognostic value depends on the chosen statistical analysis method. Appropriate statistical analyses of prognostic factors in cohort studies should be considered and should enable valuable and reproducible conclusions.

Indexed as

biological parametercohortsickle cell disease

Identifiers

PMID33668629
PMCPMC7917793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.